Fidelis Insurance (NYSE:FIHL) Price Target Cut to $23.00 by Analysts at Keefe, Bruyette & Woods

Fidelis Insurance (NYSE:FIHL) had its price target lowered by analysts at Keefe, Bruyette & Woods from $24.00 to $23.00 in a research report issued on Friday, Marketbeat.com reports. The brokerage presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price target points to a potential upside of 24.76% from the company’s current price.

A number of other research firms have also weighed in on FIHL. Evercore ISI raised their price objective on shares of Fidelis Insurance from $19.00 to $20.00 and gave the company an “in-line” rating in a research note on Thursday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Fidelis Insurance in a research note on Wednesday, October 8th. Barclays increased their price objective on Fidelis Insurance from $17.00 to $19.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded Fidelis Insurance from a “strong sell” rating to a “hold” rating in a report on Thursday, September 11th. Four research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Fidelis Insurance currently has an average rating of “Hold” and a consensus target price of $21.14.

Fidelis Insurance Trading Down 1.3%

FIHL traded down $0.25 during trading on Friday, reaching $18.44. 144,983 shares of the stock traded hands, compared to its average volume of 602,117. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.36. The stock’s 50-day moving average is $18.01 and its 200 day moving average is $17.08. Fidelis Insurance has a 12 month low of $14.17 and a 12 month high of $20.85. The stock has a market capitalization of $2.04 billion, a PE ratio of -369.10 and a beta of 0.27.

Fidelis Insurance (NYSE:FIHL) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.02. Fidelis Insurance had a negative return on equity of 0.95% and a negative net margin of 0.56%.The firm had revenue of $797.50 million for the quarter, compared to analysts’ expectations of $676.79 million. Equities analysts anticipate that Fidelis Insurance will post 3.12 earnings per share for the current year.

Institutional Investors Weigh In On Fidelis Insurance

Several hedge funds have recently bought and sold shares of the stock. North Capital Inc. bought a new position in Fidelis Insurance in the 2nd quarter worth $33,000. Ameritas Investment Partners Inc. boosted its stake in shares of Fidelis Insurance by 15.3% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 6,088 shares of the company’s stock valued at $101,000 after purchasing an additional 810 shares in the last quarter. CWM LLC increased its position in shares of Fidelis Insurance by 444.4% during the second quarter. CWM LLC now owns 7,131 shares of the company’s stock valued at $118,000 after buying an additional 5,821 shares during the period. Tower Research Capital LLC TRC increased its position in shares of Fidelis Insurance by 58.9% during the second quarter. Tower Research Capital LLC TRC now owns 7,786 shares of the company’s stock valued at $129,000 after buying an additional 2,885 shares during the period. Finally, EMC Capital Management bought a new position in Fidelis Insurance in the second quarter worth about $131,000. 81.99% of the stock is currently owned by institutional investors.

Fidelis Insurance Company Profile

Fidelis Insurance Holdings Limited, a specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom. It operates in three segments: Specialty, Reinsurance, and Bespoke segments. The Specialty segment offers aviation and aerospace, energy, marine, property direct and facultative, and other specialty risk solutions.